Table of contents
Volume 99, Issue 3
Published online 29 July 2008 (385-556)
Minireviews |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor |
Corrigendum
Editorial
Promises and caveats of in silico biomarker discovery FREE
L Pusztai and B Leyland-Jones
Br J Cancer 99: 385-386; doi:10.1038/sj.bjc.6604495
Minireviews
Resistance to chemotherapy: new treatments and novel insights into an old problem FREE
S Raguz and E Yagüe
Br J Cancer 99: 387-391; advance online publication, July 29, 2008; doi:10.1038/sj.bjc.6604510
Tumour-targeted nanomedicines: principles and practice FREE
T Lammers, W E Hennink and G Storm
Br J Cancer 99: 392-397; advance online publication, July 22, 2008; doi:10.1038/sj.bjc.6604483
Clinical Studies
PRAME expression and clinical outcome of breast cancer FREE
M T Epping, A A M Hart, A M Glas, O Krijgsman and R Bernards
Br J Cancer 99: 398-403; advance online publication, July 22, 2008; doi:10.1038/sj.bjc.6604494
High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study FREE
N Akil, A Yasmeen, A Kassab, L Ghabreau, A D Darnel and A-E Al Moustafa
Br J Cancer 99: 404-407; advance online publication, July 22, 2008; doi:10.1038/sj.bjc.6604503
Human papillomavirus detected in female breast carcinomas in Japan FREE
N A Khan, A Castillo, C Koriyama, Y Kijima, Y Umekita, Y Ohi, M Higashi, Y Sagara, H Yoshinaka, T Tsuji, S Natsugoe, T Douchi, Y Eizuru and S Akiba
Br J Cancer 99: 408-414; advance online publication, July 22, 2008; doi:10.1038/sj.bjc.6604502
Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT FREE
M Klinkhammer-Schalke, M Koller, C Ehret, B Steinger, B Ernst, J C Wyatt, F Hofstädter and W Lorenz for the Regensburg QoL Study Group
Br J Cancer 99: 415-422; doi:10.1038/sj.bjc.6604505
Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction FREE
D Puliti, G Miccinesi, N Collina, V De Lisi, M Federico, S Ferretti, A C Finarelli, F Foca, L Mangone, C Naldoni, M Petrella, A Ponti, N Segnan, A Sigona, M Zarcone, M Zorzi, M Zappa and E Paci the IMPACT Working Group
Br J Cancer 99: 423-427; doi:10.1038/sj.bjc.6604532
Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer FREE
U Güth, D J Huang, A Schötzau, R Zanetti-Dällenbach, W Holzgreve, J Bitzer and E Wight
Br J Cancer 99: 428-433; advance online publication, July 29, 2008; doi:10.1038/sj.bjc.6604525
Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis FREE
H G Mulholland, L J Murray, C R Cardwell and M M Cantwell
Br J Cancer 99: 434-441; doi:10.1038/sj.bjc.6604496
Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer FREE
S Baka, R Califano, R Ferraldeschi, L Aschroft, N Thatcher, P Taylor, C Faivre-Finn, F Blackhall and P Lorigan
Br J Cancer 99: 442-447; doi:10.1038/sj.bjc.6604480
The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation FREE
P Wolter, C Stefan, B Decallonne, H Dumez, M Bex, P Carmeliet and P Schöffski
Br J Cancer 99: 448-454; advance online publication, July 29, 2008; doi:10.1038/sj.bjc.6604497
Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial FREE
P Martín-Martorell, S Roselló, E Rodríguez-Braun, I Chirivella, A Bosch and A Cervantes
Br J Cancer 99: 455-458; advance online publication, July 29, 2008; doi:10.1038/sj.bjc.6604530
Translational Therapeutics
Reciprocal relationship between expression of hypoxia inducible factor 1
(HIF-1) and the pro-apoptotic protein Bid in ex vivo colorectal cancer FREE
M M Seenath, D Roberts, C Cawthorne, M P Saunders, G R Armstrong, S T O'Dwyer, I J Stratford, C Dive and A G Renehan
Br J Cancer 99: 459-463; advance online publication, July 22, 2008; doi:10.1038/sj.bjc.6604474
The xc - cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance FREE
M Lo, V Ling, Y Z Wang and P W Gout
Br J Cancer 99: 464-472; advance online publication, July 22, 2008; doi:10.1038/sj.bjc.6604485
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs FREE
T Gelardi, R Caputo, V Damiano, G Daniele, S Pepe, F Ciardiello, M Lahn, R Bianco and G Tortora
Br J Cancer 99: 473-480; doi:10.1038/sj.bjc.6604493
[18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study FREE
W G E Direcks, S C Berndsen, N Proost, G J Peters, J Balzarini, M D Spreeuwenberg, A A Lammertsma and C F M Molthoff
Br J Cancer 99: 481-487; advance online publication, July 29, 2008; doi:10.1038/sj.bjc.6604523
Molecular Diagnostics
The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias FREE
I S Mahmoud, M A Sughayer, H A Mohammad, A A Eshtayeh, A S Awidi, M S EL-Khateeb and S I Ismail
Br J Cancer 99: 488-490; advance online publication, July 29, 2008; doi:10.1038/sj.bjc.6604512
Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer FREE
K A Landers, H Samaratunga, L Teng, M Buck, M J Burger, B Scells, M F Lavin and R A Gardiner
Br J Cancer 99: 491-501; advance online publication, July 22, 2008; doi:10.1038/sj.bjc.6604486
Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells FREE
G O'Callaghan, J Kelly, F Shanahan and A Houston
Br J Cancer 99: 502-512; advance online publication, July 22, 2008; doi:10.1038/sj.bjc.6604490
Genomic instability and proliferative activity as risk factors for distant metastases in breast cancer FREE
L Li, K Mu, G Zhou, L Lan, G Auer and A Zetterberg
Br J Cancer 99: 513-519; doi:10.1038/sj.bjc.6604479
MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells FREE
M P Ponnusamy, A P Singh, M Jain, S Chakraborty, N Moniaux and S K Batra
Br J Cancer 99: 520-526; doi:10.1038/sj.bjc.6604517
Epidemiology
Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States) FREE
J Luo, K L Margolis, H-O Adami, A LaCroix and W Ye For the Women's Health Initiative Investigators
Br J Cancer 99: 527-531; advance online publication, July 15, 2008; doi:10.1038/sj.bjc.6604487
Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology FREE
H Brenner, M Hoffmeister and U Haug
Br J Cancer 99: 532-535; advance online publication, July 15, 2008; doi:10.1038/sj.bjc.6604488
Modification of second cancer risk after malignant melanoma by parental history of cancer FREE
H Zhang, J Lorenzo Bermejo, J Sundquist and K Hemminki
Br J Cancer 99: 536-538; advance online publication, July 15, 2008; doi:10.1038/sj.bjc.6604489
Second breast cancers in a Tuscan case series: characteristics, prognosis, and predictors of survival FREE
S Ciatto, N Houssami, F Martinelli, R Bonardi, F H Cafferty and S W Duffy
Br J Cancer 99: 539-544; advance online publication, July 15, 2008; doi:10.1038/sj.bjc.6604481
Childhood cancer in the offspring born in 1921–1984 to US radiologic technologists FREE
K J Johnson, B H Alexander, M M Doody, A J Sigurdson, M S Linet, L G Spector, R W Hoffbeck, S L Simon, R M Weinstock and J A Ross
Br J Cancer 99: 545-550; advance online publication, July 29, 2008; doi:10.1038/sj.bjc.6604516
Letters to the Editor
Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer FREE
F Di Fiore, F Charbonnier, B Lefebure, M Laurent, F Le Pessot, P Michel and T Frebourg
Br J Cancer 99: 551-552; advance online publication, July 1, 2008; doi:10.1038/sj.bjc.6604451
Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy FREE
K Jung
Br J Cancer 99: 553-554; advance online publication, July 22, 2008; doi:10.1038/sj.bjc.6604491
Reply: Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy FREE
N G Hurst
Br J Cancer 99: 555; advance online publication, July 22, 2008; doi:10.1038/sj.bjc.6604492
Corrigendum
Reply: Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients FREE
N G Hurst, D D Stocken, S Wilson, C Keh, M J O Wakelam and T Ismail
Br J Cancer 99: 556; doi:10.1038/sj.bjc.6604543
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
